生物制剂应用20150604.pptVIP

* Objectives: To determine medication trends in rheumatoid arthritis patients over the past 7 years using a large observational US data bank. Methods: Participants were members of the US National Data Bank for Rheumatic Diseases longitudinal study of rheumatic disease outcomes. Between July 1998 and June 2005, we followed 10,982 RA patients (23.5% male, average initial age and disease duration of 59.5 and 12.9 years respectively) who were enrolled in the data bank by 411 community rheumatologists. Patients represented ordinary clinical practice and were not recruited as part of treatment or s